TD Cowen analyst Itay Michaeli lowered the firm’s price target on Cerence (CRNC) to $10 from $11.50 and keeps a Hold rating on the shares. Though the firm remains constructive on the GenAI penetration story and Cerence’s positioning after the company reported a fiscal Q2 beat and revised up its FY25 EBITDA and cash flow guidance, TD notes it lowered its price target on lower auto production forecasts.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRNC:
- Cerence Inc. Surpasses Earnings Expectations with Strong Q2 Performance
- Cerence price target lowered to $10 from $12 at Wells Fargo
- Buy Rating for Cerence Amid Strong Performance and Strategic Positioning Despite Tariff Uncertainties
- Cerence Inc. Surpasses Earnings Expectations in Q2 2025
- Cerence reports Q2 EPS 46c, consensus 30c
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue